BACKGROUND: The lack of reliable biomarkers to track disease progression is a major problem in clinical research of chronic neurological disorders. Using Huntington's disease (HD) as an example, we describe a novel approach to model HD and show that the progression of a neurological disorder can be predicted for individual patients. METHODS: Starting with an initial cohort of 343 patients with HD that we have followed since 1995, we used data from 68 patients that satisfied our filtering criteria to model disease progression, based on the Unified Huntington's Disease Rating Scale (UHDRS), a measure that is routinely used in HD clinics worldwide. RESULTS: Our model was validated by: (A) extrapolating our equation to model the age of disease ...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
Background and Objectives: Longitudinal measurements of brain atrophy using structural MRI (sMRI) ca...
BACKGROUND: The lack of reliable biomarkers to track disease progression is a major problem in clini...
peer reviewedBackground: The lack of reliable biomarkers to track disease progression is a major pr...
International audienceVariability in neurodegenerative disease progression poses great challenges fo...
Objective: Determining the sequence in which Huntington's disease biomarkers become abnormal can pro...
Huntington disease (HD) can be seen as a model neurodegenerative disorder, in that it is caused by a...
Huntington Disease (HD) is a progressive, neurodegenerative disorder caused by a CAG repeat expansi...
Huntington's disease (HD) is a neurodegenerative disorder caused by an unstable CAG repeat. For pati...
Huntington's disease (HD) is a neurodegenerative disorder caused by an unstable CAG repeat. For pati...
The Unified Huntington's Disease Rating Scale is used to characterize motor impairments and establis...
The Unified Huntington's Disease Rating Scale is used to characterize motor impairments and establis...
Background Potential therapeutic targets and clinical trials for Huntingtonʼs disease have grown imm...
BackgroundAlthough the association between cytosine-adenine-guanine (CAG) repeat length and age at o...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
Background and Objectives: Longitudinal measurements of brain atrophy using structural MRI (sMRI) ca...
BACKGROUND: The lack of reliable biomarkers to track disease progression is a major problem in clini...
peer reviewedBackground: The lack of reliable biomarkers to track disease progression is a major pr...
International audienceVariability in neurodegenerative disease progression poses great challenges fo...
Objective: Determining the sequence in which Huntington's disease biomarkers become abnormal can pro...
Huntington disease (HD) can be seen as a model neurodegenerative disorder, in that it is caused by a...
Huntington Disease (HD) is a progressive, neurodegenerative disorder caused by a CAG repeat expansi...
Huntington's disease (HD) is a neurodegenerative disorder caused by an unstable CAG repeat. For pati...
Huntington's disease (HD) is a neurodegenerative disorder caused by an unstable CAG repeat. For pati...
The Unified Huntington's Disease Rating Scale is used to characterize motor impairments and establis...
The Unified Huntington's Disease Rating Scale is used to characterize motor impairments and establis...
Background Potential therapeutic targets and clinical trials for Huntingtonʼs disease have grown imm...
BackgroundAlthough the association between cytosine-adenine-guanine (CAG) repeat length and age at o...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
There is growing consensus that intervention and treatment of Huntington disease (HD) should occur a...
Background and Objectives: Longitudinal measurements of brain atrophy using structural MRI (sMRI) ca...